Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

Happy Holidays from Cafepharma

We hope you're having an enjoyable holiday season. We will be updating the front page news on a limited basis throughout the rest of the year. Cafepharma Today will resume on January 2nd.

To allow its staff to spend holiday time with their families, the Cafepharma Message Boards will be switched to read-only from 6:00 PM Eastern time on Tuesday, December 24 until 9:00 PM Eastern time on Wednesday, December 25. During this time, all posts will be available for view. However, no one will be able to make new posts during this time.
*please scroll down for all the latest news*

Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe

Today's most popular searches:

Current News

submit a press release

Click here to stay updated on CP happenings

FDA Approves AstraZeneca and Merck's Lynparza for Pancreatic Cancer

BioSpace

Monday, December 30, 2019 - 5:39pm

tags:

AstraZeneca, Merck, Lynparza, pancreatic cancer, FDA

FDA clears Eisai’s insomnia drug Dayvigo

Pharmaforum

Monday, December 30, 2019 - 11:01am

tags:

FDA, Eisai, Dayvigo, insomnia, Merck, Belsomra

Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million

Reuters

Monday, December 30, 2019 - 10:59am

tags:

Astellas, Xyphos Biosciences, M&A, Audentes Therapeutics

3 challenges to watch in global health in 2020

Stat

Monday, December 30, 2019 - 10:41am

tags:

global health, polio, dengue, vaccines, viral infections

Gilead gets ball rolling on JAKs game in Japan

Endpoints

Monday, December 30, 2019 - 10:39am

tags:

Gilead Sciences, Japan, filgotinib, Eisai, rheumatoid arthritis

Spring Bank Pharma shares slide 45% premarket after it halts trial of treatment for hepatitis B virus

Marketwatch

Monday, December 30, 2019 - 10:37am

tags:

Spring Bank Pharmaceuticals, hepatitis B, clinical trials, FDA, inarigivir soproxil

3 trends in biotech to watch in 2020

Stat

Monday, December 30, 2019 - 10:34am

tags:

IPOs, eteplirsen, CAR-T, gene therapy, cell therapy, biotech

2 Biotech Stocks Poised to Soar in 2020

Motley Fool

Monday, December 30, 2019 - 10:32am

tags:

Acadia Pharmaceuticals, Axsome Therapeutics, M&A

FDA makes it official, once again rejecting battered Correvio’s heart drug

Endpoints

Monday, December 30, 2019 - 9:55am

tags:

FDA, complete response letter, Correvio, Vernakalant, atrial fibrillation

As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis

Endpoints

Thursday, December 26, 2019 - 1:18pm

tags:

Pfizer, Bristol-Myers Squibb, FDA, generics, bloodthinners, Eliquis, Micro Labs, Mylan

Spectrum Pharma Shares Slump After Lung-Cancer Drug Doesn't Meet Phase II Endpoint

TheStreet.com

Thursday, December 26, 2019 - 1:16pm

tags:

Spectrum Pharma, lung cancer, clinical trials, poziotinib, non-small cell lung cancer

UCB to build €300M biologics plant, add 150 workers

Fierce Pharma

Thursday, December 26, 2019 - 1:13pm

tags:

UCB Pharma, biologics, drug manufacturing, Belgium

Intra-Cellular approval keeps focus on FDA's neuroscience review process

BioPharma Dive

Thursday, December 26, 2019 - 1:05pm

tags:

FDA, Intra-Cellular Therapies, lumateperone, schizophrenia, Caplyta

Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal

Xconomy

Tuesday, December 24, 2019 - 12:00am

tags:

Roche, Sarepta Therapeutics, FDA, Duchenne Muscular Dystrophy, SRP-9001

Allergan scores year-end FDA nod for CGRP migraine med Ubrelvy, plans early 2020 launch

Fierce Pharma

Monday, December 23, 2019 - 11:56pm

tags:

Allergan, UIbrelvy, ubrogepant, FDA, migraines, CGRPs

Pfizer Strikes JAK Inhibitor Deal Worth Up to $250 Million With Theravance

BioSpace

Monday, December 23, 2019 - 11:52pm

tags:

Pfizer, Theravance, JAK inhibitors

Cirius withdraws $86M IPO as vaunted 'Year of NASH' draws to brutal close

Endpoints

Monday, December 23, 2019 - 11:50pm

tags:

Cirius Therapeutics, NASH

Progenics Plans to Seek Approval for Prostate Cancer Imaging Tool Following Phase III Results

BioSpace

Monday, December 23, 2019 - 11:48pm

tags:

Progenics Pharmaceuticals, prostate cancer, PyL, cancer imaging, diagnostics

FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing

Pharmaforum

Monday, December 23, 2019 - 11:46pm

tags:

FDA, AstraZeneca, Daiichi Sankyo, advanced breast cancer, Enhertu

FDA slams GSK's monthly HIV injectable with CRL, citing manufacturing issues

Endpoints

Monday, December 23, 2019 - 11:44pm

tags:

FDA, complete response letter, GSK, HIV, cabotegravir, rilpivirine

Pages

Latest CP Wire Articles

PDS Biotechnology Files for $14 Million Offering

Processa Pharmaceuticals Files for $15 Million Offering

[release] ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

MedReps survey finds best companies to work for in 2020

[release] eyeforpharma Awards Recognize Two ACTO Use Cases as Finalists

Karuna Therapeutics Files for $52 Million Offering

Biocept Files for $27 Million Offering

Highlights: 2019 Cardiometabolic Health Congress, Chicago IL

Microbiome Report

TELA Bio Files for $69 Million IPO

Latest Pharmagather Articles

Turning Commercial Compliance Roadblocks into a Springboard for Innovation

pharmexec sales

Turning Commercial Compliance Roadblocks into a Springboard for Innovation

pharmexec marketing

How Express Scripts Plans to Disrupt the Emerging Cell and Gene Therapy Channel (rerun)

Drug Channels

What were the most important lessons in Life Sciences in 2019?

Elsevier

Remaining Aloof from Politics

eye on fda

Employers Slowly Warm to Point-of-Sale Rebates—But Must Move Faster for Insulin (rerun)

Drug Channels

Proteins as Oral Drugs: Possible, But Not Probable

In the Pipeline

A CVS Lawsuit Uncovers Three Surprising Revelations about Amazon’s PillPack Strategy (rerun)

Drug Channels

Unprecedented Times for Market Access: Amy Mahery

pharmexec top feature

Pharma Jobs from Indeed

Indeed